Bills › 88th General Assembly
Relating to insurance coverage for diagnostic breast cancer examinations and prescription drugs used in the treatment of stage IV cancer, and including applicability provisions
Where it is now
- Done: IntroducedFebruary 10, 2020
- Done: SubcommitteeFebruary 12, 2020
- Stopped: Senate committeeDied when the General Assembly ended
- Next: Passes the Senate
- Next: House committee
- Next: Passes the House
- Next: To the Governor
- Next: Signed into law
Died when the session ended The 2020 session adjourned on June 14, 2020, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?
What’s in it
This bill relates to insurance coverage for diagnostic breast cancer examinations and prescription drugs used in the treatment of stage IV cancer. The bill requires a policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses to provide coverage for diagnostic breast cancer examinations. “Diagnostic breast cancer examination” is defined in the bill as an examination of an abnormality, deemed medically necessary by a covered person’s health care professional, for the detection of breast cancer.
Read the full explanation
The examination may be conducted using a diagnostic mammogram, breast magnetic resonance imaging, or breast ultrasound. “Abnormality”, “diagnostic mammogram”, “breast magnetic resonance imaging”, and “breast ultrasound” are also defined in the bill. The policy, contract, or plan cannot require cost-sharing greater than the cost-sharing that the policy, contract, or plan requires for a screening mammogram. “Cost-sharing” and “screening mammogram” are defined in the bill. The bill also requires policies, contracts, or plans providing for third-party payment or prepayment of health or medical expenses that provide coverage for prescription drugs to provide coverage for prescription cancer drugs. “Prescription cancer drug” is defined in the bill as a prescription drug that is used to treat stage IV cancer. “Stage IV cancer” is also defined in the bill. The policy, contract, or plan is required to provide coverage, without imposing a step therapy protocol, for a prescription cancer drug that has been approved by the United States food and drug administration, the use of which is in accordance with medical standards of care for stage IV cancer, and the use of which is supported by peer-reviewed, evidence-based literature. “Step therapy protocol” is defined in the bill as a protocol or program that establishes a specific sequence in which prescription drugs for a specified medical condition and medically appropriate for a particular covered person are covered under a pharmacy or medical benefit by a health carrier, a health benefit plan, or a utilization review organization, including self-administered drugs and drugs administered by a health care professional. The bill applies to third-party payment providers enumerated in the bill. The bill specifies the types of specialized health-related insurance which are not subject to the coverage requirements of the bill. The commissioner of insurance is required to adopt rules to administer the requirements of the bill. The bill applies to third-party payment provider contracts, policies, or plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2021.
Senate subcommittee
Named February 12, 2020. Meeting: Tuesday, February 18 · 10:30 AM · RM G17.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Iowa Code it changes
Lobbying
3 for · 0 against · 8 undecided · Who →
Similar bills
- SSB 3161 SSB 316188th General Assembly · Renumbered as SF 2384Similar
- SF 116 Relating to insurance coverage for prescription drugs used in the treatment of metastatic …89th General Assembly · In committeeSimilar
- SF 2165 Relating to insurance coverage for prescription drugs used in the treatment of metastatic …89th General Assembly · In committeeSimilar
- HF 873 Relating to insurance coverage for prescription drugs used in the treatment of stage IV ca…89th General Assembly · In committeeSimilar
Matched by wording or an identical title.